Stephen I. Pelton, MD
Professor, Pediatrics
Biography
Stephen I Pelton MD is Professor of Pediatrics and Epidemiology at Chobanian and Avedisian School of Medicine and Public Health and Director of Pediatrics Infectious Diseases at Boston Medical Center. Dr Pelton’s interests focus on the effects of recurrent disease and the long term effects of HIV, Hepatitis C and B, and Herpes among other things. Additionally, he organizes numerous clinical trials to discover new approaches to HIV prevention and treatment.
Other Positions
- Director (Section) of Pediatrics>Infectious Disease, Infectious Diseases, Pediatrics, Boston University Chobanian & Avedisian School of Medicine
- Member, Pulmonary Center, Boston University
- Professor, Epidemiology, Boston University School of Public Health
Education
- State University of New York at Buffalo, MD
- Queens College, City University of New York, BA
Publications
- Published on 1/20/2025
Rozen Eisenberg I, Campbell JI, Clarke D, Cooper ER, Pelton SI, Vuppula SS. Practice Variability in Uptake and Implementation of New U.S. DHHS Guidelines for Feeding of HIV-Exposed Infants. J Pediatric Infect Dis Soc. 2025 Jan 20; 14(1). PMID: 39726301.
Read at: PubMed - Published on 1/7/2025
Yildirim M, Keskinocak P, Hinderstein S, Tran K, Dasthagirisaheb YBS, Madoff L, Pelton S, Yildirim I. A comprehensive analysis of serotype-specific invasive capacity, clinical presentations, and mortality trends of invasive pneumococcal disease. Vaccine. 2025 Feb 15; 47:126692. PMID: 39778476.
Read at: PubMed - Published on 10/4/2024
Kochis EJ, Shaik-Dasthagirisaheb YB, Munarriz N, Kretzmann I, Nahm M, Pelton SI, Lapidot R. Serotype 15C Streptococcus pneumoniae resistant to classical complement deposition and agglutination by polyclonal rabbit anti-capsular 15B sera. Vaccine. 2024 Dec 02; 42(26):126419. PMID: 39368131.
Read at: PubMed - Published on 7/3/2024
McGovern I, Chastek B, Bancroft T, Webb N, Imran M, Pelton SI, Haag MDM. Relative vaccine effectiveness of MF59-adjuvanted vs high-dose trivalent inactivated influenza vaccines for prevention of test-confirmed influenza hospitalizations during the 2017-2020 influenza seasons. Int J Infect Dis. 2024 Sep; 146:107160. PMID: 38969330.
Read at: PubMed - Published on 6/4/2024
Fisman D, Giglio N, Levin MJ, Nguyen VH, Pelton SI, Postma M, Ruiz-Aragón J, Urueña A, Mould-Quevedo JF. The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analyses. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2351675. PMID: 38835218.
Read at: PubMed - Published on 5/24/2024
Hurst JH, Shaik-Dasthagirisaheb YB, Truong L, Boiditswe SC, Patel SM, Gilchrist J, Maciejewski J, Luinstra K, Smieja M, Steenhoff AP, Cunningham CK, Pelton SI, Kelly MS. Serotype epidemiology and antibiotic resistance of pneumococcal isolates colonizing infants in Botswana (2016-2019). PLoS One. 2024; 19(5):e0302400. PMID: 38787847.
Read at: PubMed - Published on 1/1/2024
Yildirim I, Lapidot R, Shaik-Dasthagirisaheb YB, Hinderstein S, Lee H, Klevens M, Grant L, Arguedas Mohs AG, Cane A, Madoff L, Johnson H, Ivanof C, Burns M, Pelton S. Invasive Pneumococcal Disease After 2 Decades of Pneumococcal Conjugate Vaccine Use. Pediatrics. 2024 Jan 01; 153(1). PMID: 38087952.
Read at: PubMed - Published on 12/19/2023
Levin MJ, Divino V, Postma MJ, Pelton SI, Zhou Z, DeKoven M, Mould-Quevedo J. A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasons. Expert Rev Vaccines. 2024; 23(1):124-136. PMID: 38073493.
Read at: PubMed - Published on 12/14/2023
Pelton SI, Mould-Quevedo JF, Nguyen VH. Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US. Expert Rev Vaccines. 2024; 23(1):82-87. PMID: 38093415.
Read at: PubMed - Published on 11/13/2023
Pelton SI, Hullegie S, Leach AJ, Marchisio P, Marom T, Sabharwal V, Shaikh N, Tähtinen PA, Venekamp RP. ISOM 2023 Research Panel 5: Interventions- Vaccines and prevention, medical and surgical treatment, and impact of COVID-19 pandemic. Int J Pediatr Otorhinolaryngol. 2024 Jan; 176:111782. PMID: 38000342.
Read at: PubMed
View 307 more publications: View full profile at BUMC